# Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

> **NCT00029380** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 30 (estimated)

## Conditions studied

- Hematologic Diseases
- Anemia, Sickle Cell
- Beta-Thalassemia
- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Sangstat
- **DRUG:** Cyclophosphamide
- **DRUG:** Busulfan
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Cyclosporine
- **PROCEDURE:** Cord Blood Transplantation

## Key facts

- **NCT ID:** NCT00029380
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00029380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00029380, "Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00029380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*